Deca-Durabolin

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Buy It Now

Active ingredient:

Nandrolone decanoate

Available from:

Merck Sharp & Dohme Australia Pty Ltd

Class:

Medicine Registered

Patient Information leaflet

                                DECA-DURABOLIN
 
_Nandrolone decanoate_
CONSUMER MEDICINE INFORMATION
   
 
 
WHAT IS IN THIS LEAFLET
This leaflet answers some common
questions about Deca-Durabolin.
It does not contain all the available
information.
It does not take the place of talking to
your doctor or pharmacist.
All medicines have risks and
benefits. Your doctor has weighed
the risks of you using Deca-
Durabolin against the benefits they
expect it will have for you.
A doctor's prescription is required to
obtain this medicine.
IF YOU HAVE ANY CONCERNS ABOUT
USING THIS MEDICINE, ASK YOUR
DOCTOR OR PHARMACIST.
READ ALL OF THIS LEAFLET CAREFULLY
BEFORE YOU START USING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
KEEP THIS INFORMATION WITH THE
PACK.
You may need to read it again.
This medicine has been prescribed
for you only. Do not pass it on to
others. It may harm them, even if
their signs of illness are the same as
yours.
If you get any side effects talk to
your doctor or pharmacist. This
includes any possible side effects not
listed in this leaflet.
WHAT DECA-DURABOLIN
IS USED FOR
Deca-Durabolin is a clear yellow oily
solution for injection containing 50
mg/ml of the active ingredient
nandrolone decanoate.
It is used to treat:
•
osteoporosis (loss of bone tissue)
•
certain types of anaemia
•
breast cancer (in women)
•
patients on long term
corticosteroids.
It belongs to a group of medicines
known as anabolic steroids.
These medicines help to rebuild
tissues that have become weak
because of continuing illness or
serious injury. Deca-Durabolin can
be used to increase lean body mass in
the case of negative nitrogen balance.
It can also be used to increase bone
mass and stimulate the formation of
red blood cells in the bone marrow.
Your doctor may have prescribed it
for another reason.
ASK YOUR DOCTOR IF YOU HAVE ANY
QUESTIONS ABOUT WHY THIS MEDICINE
HAS BEEN PRESCRIBED FOR YOU.
ABILITY TO DRIVE OR OPERATE
MACHINERY.
As far as is known, Deca-Durabolin
has no adverse effect on driving and
using machines.
BEFORE 
                                
                                Read the complete document
                                
                            

Summary of Product characteristics

                                 
-1- 
PRODUCT INFORMATION 
 
DECA-DURABOLIN
®
  
 
_(nandrolone decanoate) _
 
 
NAME OF THE MEDICINE 
_ _
DECA-DURABOLIN
®
 50 MG/ML (Solution for injection of nandrolone decanoate) _ _
_ _
_ _
_ _
_ _
_Molecular Formula: C_
_28_
_H_
_44_
_O_
_3 _
_Molecular mass: 428.7  Cas. No: 360-70-3 _
_Chemical Name: 3-oxo-estr-4-en-17_

_-yl decanoate _
 
Deca-Durabolin is an androgenic oily preparation for
intramuscular administration.  
 
DESCRIPTION 
 
Nandrolone decanoate is a white to creamy white, crystalline
powder. It is practically insoluble in water 
but is freely soluble in chloroform, ethanol, ether,
fixed oils and esters. 
 
Deca-Durabolin comes in 1 mL pre-filled
syringes containing 1 mL of light yellow oily liquid. 
 
Each pre-filled syringe
contains 1 ml of 50 mg/mL nandrolone decanoate. 
 
COMPOSITION
 
 
Each ml of Deca-Durabolin contains 50 mg of the active
ingredient nandrolone decanoate. The 
product also contains the inactive
ingredients benzyl alcohol (0.1 mL) and arachis (peanut) oil making 
up the volume. 
 
PHARMACOLOGY 
 
PHARMACODYNAMIC PROPERTIES 
 
Deca-Durabolin is an injectable
anabolic preparation. The pharmacologically active substance is 
nandrolone. The decanoate ester gives the preparation a duration
of action of about three weeks after 
injection. 
 
Nandrolone is chemically related to the male hormone.
Compared to testosterone, it has an enhanced 
anabolic and a reduced androgenic activity.
This has been demonstrated in animal bioassays and 
explained by receptor binding studies.
The low androgenicity of nandrolone is confirmed in clinical 
use. In the human, Deca-Durabolin has been shown
to positively influence calcium metabolism and to 
increase bone mass in osteoporosis.
In women with disseminated mammary carcinoma, Deca-
Durabolin has been reported to produce objective regre
                                
                                Read the complete document
                                
                            

Search alerts related to this product

View documents history